Showing results (371-380 of 384) with videos related to

Sort By:
Pageof 39
The Journal of Clinical Endocrinology and Metabolism|July 23, 2024
Vaccinome Landscape in Nearly 620 000 Patients With DiabetesFrancesca D'Addio, Elisa Lazzaroni, Maria Elena Lunati, et al.
Diabetes|May 13, 2022
Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 DiabetesFrancesca D'Addio, Gianmarco Sabiu, Vera Usuelli, et al.
Pharmacological Research|July 31, 2022
Dapagliflozin acutely improves kidney function in type 2 diabetes mellitus. The PRECARE studyElisa Lazzaroni, Maria Elena Lunati, Laura Montefusco, et al.
Trials|July 27, 2020
Expression levels of circulating miRNAs as biomarkers during multimodal treatment of rectal cancer - TiMiSNAR-mirna: a substudy of the TiMiSNAR Trial (NCT03962088)Igor Monsellato, Elisabetta Garibaldi, Elisa Cassinotti, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|March 27, 2025
Comparing local excision with watch and wait for the management of rectal cancer patients responding to neoadjuvant chemoradiotherapy: Composite endpoint analysis using the win ratioGiulia Capelli, Giulia Lorenzoni, Maria Vittoria Chiaruttini, et al.
Nature Metabolism|May 26, 2021
Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infectionLaura Montefusco, Moufida Ben Nasr, Francesca D'Addio, et al.
BMC Cancer|February 19, 2020
Correction to: Standard (8 weeks) vs long (12 weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR)Igor Monsellato, Filippo Alongi, Elisa Bertocchi, et al.
BMC Cancer|December 18, 2019
Standard (8 weeks) vs long (12 weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR)Igor Monsellato, Filippo Alongi, Elisa Bertocchi, et al.
Diabetes|May 2, 2022
Indirect and Direct Effects of SARS-CoV-2 on Human Pancreatic IsletsMoufida Ben Nasr, Francesca D'Addio, Laura Montefusco, et al.
Free Radical Biology & Medicine|September 18, 2023
NECAB2 is an endosomal protein important for striatal functionDiones Bueno, Partha Narayan Dey, Teresa Schacht, et al.
Pageof 39